Kristina Meyer

Biography

 Dr Meyer brings more than 15 years of commercial and business development experience in the international biotech industry to the company. Kristina joined Inventiva in 2015 from Oxford BioTherapeutics where she was responsible for the outlicensing of pre-clinical oncology assets, in-licensing of antibody arming technologies, oncology target discovery collaborations and alliance management. Prior to Oxford BioTherapeutics she worked at Evotec in the USA and the UK where she had regional commercial responsibility for the discovery alliance business across various therapeutic areas and territories including Europe and the West Coast of the USA. Previously she also held a number of commercial roles of increasing responsibility in the discovery information and informatics industry including Director of Business Development at Sertany and Thieme Medial Publishers. Dr Meyer holds a Ph.D. in organic chemistry from the University of Frankfurt, Germany, and conducted post-doctoral research at Yale University in New Haven, CT, USA.

Research Interest

 Biochemistry, Analytical Chemistry